Tag
Zydus Lifesciences Limited
3 articles
Zydus LiqMeds UK USFDA Inspection Closes with 4 Observations
Zydus Lifesciences discloses closure of USFDA inspection at its UK subsidiary LiqMeds from November 9-13, 2026.
The inspection concluded with 4 observations that the company will address with USFDA ex
Zydus Lifesciences Completes Zydus Sunshine Joint Venture
Zydus Lifesciences completed its 50% equity subscription in Zydus Sunshine Lifesciences, finalizing the joint venture.
The transaction, originally expected within 90 days, was completed on November 11
Zydus Lifesciences Promoter Group Share Transmission
Zydus Lifesciences discloses off-market transmission of 32,577 shares from late Jasodaben Patel to Prashant Patel.
The disclosure is made under SEBI PIT Regulations regarding promoter group holdings.